Surgical operating room
Perioperative Peptide Protocol

Optimize Your Surgical Recovery

A four-phase evidence-informed peptide protocol designed to prime, protect, rebuild, and maintain your body before and after surgery.

4
Protocol Phases
9
Peptide Compounds
12+
Weeks Coverage
100%
Research Grade
The Protocol

Four Phases of Recovery

Each phase targets specific biological mechanisms—from immune priming weeks before your procedure to long-term cellular maintenance. Peptides are sequenced to work synergistically, not in isolation.

1

Phase 1

Pre-Operative

2–8 Weeks Before Surgery

Goal: Baseline Optimization
PeptideDoseFrequencyPurpose
BPC-157500 mcg/dayDailyGut & tissue baseline prep
Thymosin A11.6 mg2× per weekImmune system priming
Zinc Carnosine75 mg/dayDailyGI mucosal protection
2

Phase 2

Acute Post-Op

Day 0–7 After Surgery

Goal: Acute Healing
PeptideDoseFrequencyPurpose
BPC-1571,000 mcg/dayDailyAccelerate wound closure
KPV100 mcg3× per dayReduce acute inflammation
Thymosin B42 mg3× per weekCell migration & repair
3

Phase 3

Active Recovery

Week 2–8 Post-Op

Goal: Active Recovery
PeptideDoseFrequencyPurpose
BPC-157500 mcg2× per daySustained tissue remodeling
TB-5002 mg2× per weekLarge-scale regeneration
Ipamorelin200 mcg3× per dayGH pulse for anabolism
4

Phase 4

Long-Term Maintenance

Month 3 & Beyond

Goal: Long-Term Maintenance
PeptideDoseFrequencyPurpose
CJC-12951 mg/weekWeeklySustained GH axis support
Ipamorelin200 mcg3× per dayDaily GH pulse maintenance
Epitalon10 mg/dayDailyTelomere & longevity support

Accelerated Tissue Repair

BPC-157 and TB-500 upregulate growth factors like VEGF and EGF, dramatically increasing the rate of tendon, muscle, and connective tissue repair at the cellular level.

Inflammation Management

KPV and Thymosin Alpha-1 modulate the inflammatory cascade—reducing excessive immune response that delays healing without suppressing the protective acute phase.

Hormonal Optimization

CJC-1295 and Ipamorelin restore the anabolic environment needed for tissue synthesis, counteracting the catabolic stress response triggered by surgical trauma.

Important Disclaimer

The protocols presented on this page are for educational and research purposes only. They do not constitute medical advice, a diagnosis, or a treatment recommendation. Peptide compounds vary in regulatory status by jurisdiction, and many are not approved for human use by the FDA or equivalent agencies. Always consult a licensed, qualified healthcare professional before beginning any peptide protocol — especially in the perioperative setting where drug interactions and immune considerations are critical. Orthobiologic Pathways assumes no liability for decisions made based on this content.